MIE Corporation Co., Ltd (XNGO:3442)
Japan flag Japan · Delayed Price · Currency is JPY
1,461.00
-38.00 (-2.54%)
At close: Aug 6, 2025

Oncternal Therapeutics Revenue

In the fiscal year ending March 31, 2025, MIE Corporation had annual revenue of 7.10B JPY with 4.21% growth. MIE Corporation had revenue of 1.80B in the quarter ending March 31, 2025, with 10.12% growth.

Revenue
7.10B
Revenue Growth
+4.21%
P/S Ratio
0.25
Revenue / Employee
54.60M
Employees
130
Market Cap
1.80B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 20257.10B287.00M4.21%
Mar 31, 20246.81B232.00M3.53%
Mar 31, 20236.58B882.00M15.48%
Mar 31, 20225.70B859.00M17.76%
Mar 31, 20214.84B-738.00M-13.24%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Toyota Motor48.04T
Mitsubishi UFJ Financial Group5,440.78B
Sony Group12.96T
Hitachi9,830.27B
SoftBank Group7,243.75B
Nintendo1,490.65B
Sumitomo Mitsui Financial Group3,346.44B
Fast Retailing3,354.04B
Revenue Rankings